Calf Botox leg slimming at Kind Global Clinic Myeongdong is one of the most frequently requested body contouring treatments among East Asian patients, particularly Japanese, Chinese, and Korean patients in their 20s-40s who carry genetically larger gastrocnemius muscle bulk ('radish-leg' shape). The treatment uses botulinum toxin injection into the medial gastrocnemius head (the primary contributor to calf circumference in aesthetic terms) and, when indicated, the lateral gastrocnemius head, to reduce muscle volume by 20-35% over 4-8 weeks by temporary neuromuscular blockade and subsequent type II muscle fibre atrophy.
At Kind Global Clinic Myeongdong, co-directors Dr. Lee Wonjin (KR Medical License 143124, Daegu Catholic University College of Medicine, 2022) or Dr. Lee Kangin (KR Medical License 141247) personally perform all calf Botox injections. The co-director palpates the medial and lateral gastrocnemius heads under active plantar flexion to map the muscle belly, marks 5-10 injection points per head, and injects 50-100 units per medial gastrocnemius head (bilateral total: 100-200 units for standard treatment). Brand options include Allergan onabotulinumtoxinA, Korean generics (national KFDA brands), or Xeomin incobotulinumtoxinA — patients select based on brand preference and budget. All lot numbers, unit counts per injection site, and baseline leg circumference photographs are documented on the patient chart.
Calf Botox is contraindicated for patients with neuromuscular diseases (myasthenia gravis, Lambert-Eaton syndrome), pregnancy, or active calf infections. It does not significantly affect walking function at standard aesthetic dosing (up to 200 units bilateral gastrocnemius), as the soleus muscle (which also provides plantar flexion) is uninjected and maintains 80 al 90 % of functional plantar flexion force.